Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

111 Inc ADR (YI)

111 Inc ADR (YI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 540,637
  • Shares Outstanding, K 81,544
  • Annual Sales, $ 259,760 K
  • Annual Income, $ -55,280 K
  • 60-Month Beta 3.11
  • Price/Sales 1.19
  • Price/Cash Flow N/A
  • Price/Book 4.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +454,190.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.46 +48.65%
on 12/26/19
7.25 -8.55%
on 01/08/20
+1.60 (+31.81%)
since 12/17/19
3-Month
4.43 +49.66%
on 10/30/19
7.25 -8.55%
on 01/08/20
+1.78 (+36.70%)
since 10/17/19
52-Week
2.29 +189.27%
on 08/28/19
9.50 -30.21%
on 02/04/19
-1.54 (-18.85%)
since 01/17/19

Most Recent Stories

More News
111 Unveils New Video on The Impact of Chinese Policies to Medical Industry

111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced today,...

BGNE : 170.36 (+1.50%)
YI : 6.63 (+1.53%)
111 Unveils New Video on the Impact of the Internet and other New Technologies on the Medical Industry

111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the fifth episode in its 111 Insight series. The title announced today,...

BGNE : 170.36 (+1.50%)
YI : 6.63 (+1.53%)
111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference

Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled "Driving Transformation in...

YI : 6.63 (+1.53%)
111, Inc. Enters Into Strategic Partnership with Bestyoo to Upgrade Online Healthcare Service Model

111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced that it has entered into a strategic partnership with Bestyoo, a prescription information...

YI : 6.63 (+1.53%)
111 Inc to Attend the JP Morgan 2020 Healthcare Conference in San Francisco, January 14-15, 2020

111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will attend the JP Morgan 2020 Healthcare Conference in San...

YI : 6.63 (+1.53%)
111 Named "National High-tech Enterprise" by the Government

China's Ministry of Science and Technology has named 111, Inc. (NASDAQ: YI) ("111" or the "Company") a "National High-tech Enterprise", the Company announced today. The designation is one of the highest...

YI : 6.63 (+1.53%)
111 Inc. Hosts 2019 Online Pharmaceuticals and Healthcare Summit

111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, convened the China Online Pharmaceuticals and Healthcare Summit 2019 (the "Summit") together...

YI : 6.63 (+1.53%)
Tianjin Tongrentang Group Partners with Online Pharmacy Giant 111, Inc.

In a partnership combining one of China's oldest names in pharmaceuticals with one of its newest, 111, Inc. (NASDAQ: YI) ("111" or the "Company") is partnering with Tianjin Tongrentang Group. Co., Ltd....

YI : 6.63 (+1.53%)
111: 3Q Earnings Snapshot

SHANGHAI (AP) _ 111 Inc. (YI) on Thursday reported a loss of $17.2 million in its third quarter.

YI : 6.63 (+1.53%)
111, Inc. Announces Third Quarter 2019 Unaudited Financial Results

111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the third quarter ended September...

YI : 6.63 (+1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade YI with:

Business Summary

111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.

See More

Key Turning Points

2nd Resistance Point 7.32
1st Resistance Point 6.97
Last Price 6.63
1st Support Level 6.37
2nd Support Level 6.11

See More

52-Week High 9.50
Fibonacci 61.8% 6.75
Last Price 6.63
Fibonacci 50% 5.90
Fibonacci 38.2% 5.05
52-Week Low 2.29

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar